Skip to main content

Nanogen and Epoch Biosciences to Merge

NEW YORK, Sept. 7 (GenomeWeb News) - Nanogen and Epoch Biosciences have agreed to merge in an all-stock transaction, the companies said today.

 

Under the terms of the agreement, Nanogen has agreed to an offer price of $2 per Epoch share, which is a 30 percent premium over the average closing price of Epoch's shares for the 20 trading days ended Sept. 1, the companies said. Epoch shareholders will receive a number of Nanogen shares based on an exchange ratio determined by dividing the offer price by Nanogen's issue price as calculated at closing.

 

The directors of both companies have signed an agreement to vote in favor of the transaction, which, subject to approval by stockholders is expected to close by the end of this year.

 

Nanogen and Epoch have several complementary products in the molecular diagnostics field, the companies said. Specifically, Epoch's MGB Eclipse Probe System, including recently launched analyte-specific detection reagents, complement Nanogen's NanoChip molecular biology workstation. Both products are used for analyzing gene expression in vitro, detecting SNPs and mutations, and identifying infectious organisms, the companies said.

 

Nanogen said it intends to retain Epoch's R&D capabilities and reagent manufacturing operations in Bothell, Washington. Administration, marketing, and sales will be merged into Nanogen's San Diegoheadquarters.

 

Seven Hills Partners acted as financial advisor to Nanogen in the transaction, while Molecular Securities advised Epoch on the deal.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.